Updates in Hospice and Palliative Medicine and Intensive Physician Board Review Course 2026 - Online Access to Syllabus/Video Presentations Only

Updates in Hospice and Palliative Medicine and Intensive Physician Board Review Course - September 15-17, 2026

Online Access to Syllabus/Video Presentations Only $649.00

Online Access Registration Fee - Includes Online Course Materials (PowerPoint Presentation Slides, Recorded Talks, Q&A Study Bank, ABIM Blueprint)

For additional information, contact Continuing Professional Education (CPE), at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Telephone registrations are not accepted.

We accept the following forms of payment:

• Credit Cards (MasterCard, VISA, and American Express)

• Check (payable through U.S. banks only)

• Mail to: Continuing Professional Education – Unit 1781 The University of Texas MD Anderson Cancer Center P.O. Box 301407 Houston, TX 77230-1407

Make check payable to:  The University of Texas MD Anderson Cancer Center

When registering online a receipt (confirmation letter) will be automatically emailed to the e-mail address you list on the registration form.

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Sonal Admane, MD
MD Anderson

Faculty

Nothing to disclose

Monica Agosta, PsyD, Assistant Professor
Dr.
MD Anderson Cancer Center

Faculty

Kayley M. Ancy, MD
Fellow
MDACC

Faculty

Nothing to disclose

Joseph A. Arthur, MD
Associate Professor
University of Texas MD Anderson Cancer Center

Faculty

Consulting Fee-Teikoku Pharma USA

Eduardo Bruera, MD, FAAHPM
Department Chair
University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Matthew D Clark, PharmD
Clinical Pharmacy Specialist
The University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Marvin O. Delgado Guay, MD
Professor
MDACC

Faculty

Nothing to disclose

Rony Dev, DO
Associate Professor
MD Anderson Cancer Center

Faculty

Larry C. Driver, MD
Professor
The University of Texas MD Anderson Cancer Center

Faculty

Daniel E Epner , MD
Professor
UT MD Anderson Cancer Center

Faculty

Yvonne J. Heung, MD
Associate Professor
MD Anderson Cancer Center

Faculty

David Hui, MD
University of Texas MD Anderson Cancer Center

Faculty

Dhanalakshmi Koyyalagunta, MD
Professor
University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Kevin Madden, MD
University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Kristy Nguyen, PharmD, BCPS
Pharmacy Clinical Specialist
University of Texas MD Anderson Cancer Center

Faculty

Linh Nguyen, MD
MD
University of Texas MD Anderson Cancer Center

Faculty

Suresh K. Reddy, MD
Professor
University of Texas MD Anderson Cancer Center

Faculty

Nothing to disclose

Ruth M Thomson, DO, MBA, HMDC, FAAHPM, FACOI
Chief Medical Officer
Four Seasons The Care You Trust

Faculty

Jacqueline M. Tschanz, MD
Dr.
MD Anderson

Faculty

Sriram Yennu, MD
MD
UT MD Anderson Cancer Center

Faculty

Grant or research support-Pfizer Inc. (Relationship has ended)|Consulting Fee-Pfizer Inc. (Relationship has ended)